ActaOphthalmologica2014
notablyBCVAandCRT.ThisstudyalsoattemptstodeterminewhetherARAscouldactasaserumbiomarkerofthee cacyofanti-VEGFtherapy.
MaterialsandMethods
Ninetyeightpatients(108eyes)withexudativeAMDweretreatedwithin-travitrealbevacizumab(Avastin,RochePharmaAG,Mannheim,Germany).Therewere38males(39%)and60females(61%)aged55–93years(mean:76years).Exclusioncriteriaincludedthefollowing:otherretinaldiseases,uveitisand/orretinalvasculitis,para-neoplasticretinopathies,glaucoma,dia-betesanddiabeticretinopathy,theuseofsystemicsteroidand/orimmunosu-pressiveagentsandassociatedautoim-munesystemicdisease.Fiftyage-andsex-matchedhealthysubjectswithnohistoryofAMDoranychroniceyedisease,requiringsurgeryforage-relatedcataractsservedascontrols.Thecontrolgroupconsistedof20males(40%)and30females(60%)aged53–91years(mean:75.2years).
BaselineexaminationinallcasesincludedBCVA,slitlampandfundusexamination,OCTandFA.Follow-upexaminationwasperformedmonthlyandwasthesameasthebaselineexamination,exceptforangiography.Allpatientsweretreatedwithintravi-trealbevacizumab1.25mg/0.05mlevery4weeksduringthe rst3months(‘loading’phase)andthenthedecisionconcerningreinjectionwasbasedontheresultsofBCVAandOCT(‘main-tenance’phase).
InallpatientsserumARAsweredeterminedusingindirectimmuno uo-rescence(IIF)onfrozensectionsofnormalmonkeyretinaasantigenssub-strateand uoresceinisothiocyanate-labelledgoat’santi-humanIgA,G,Mserumasthesecondaryantibody(Eu-roimmunAG,Lubeck,Germany).Bloodsampleswerecollectedfromallsubjectsatthebeginningofthestudy,andthereafteratmonthlyintervals.Thesampleswerecentrifugedat1000gfor10minandstoredatÀ80°CinaliquotsuntiltestedbyIIF.Thethawedserafrompatientsandcontrolsweredilutedinaseriesoftitres:1:10,1:20,1:40,1:80etc.,accord-ingtothestandardprotocolattachedbytheproducerofthekit.IIFincuba-tionstimesandwashingswereasrec-ommendedbythemanufacturer’s
protocol.Controlserawerealsopro-cessed.Allimmunohistochemicalslideswereevaluatedbytwoindependentobserversusing uorescencemicros-copy(Axioscope equippedwithHBO100lamp).Theindependentobservers,whowereunawareofthediagnosisandthestageofdisease,recordedthelevelofstaininginalllayersoftheretinaaswellasthehighestserumdilutionwhichstillgaveapositiveresult.Duringthefollow-upperiodinpatientswhoseserademon-stratedmorethanonetypeofimmu-no uorescencepatternofreactivityagainstretinaltissue,onlythatwhichoccurredatthehighesttitresatthebaselineexaminationwasfurthereval-uatedandusedtomonitorthee ectsofanti-VEGFtherapy.Serawithaposi-tivereactionwithintheouterandinnernuclearlayersofretinawerescreenedforthepresenceofantinuclearanti-bodies(ANA)usingtheIIFmethodandHEp-2celllinesasasubstrate(EuroimmunAG).
SerumARAswereassessedatthebeginningofthestudyandthenimmu-nohistochemicalstudieswererepeatedatfourweeklyintervals.Thetotalfollow-upperiodwas8months.
ApprovalbytheJagiellonianUni-versityEthicalCommittee(KBET/165/B/2009)wasobtainedaswellasinformedconsentofallparticipatingsubjects.Statisticalanalysiswasper-formedusingthenonparametricMann-WhitneyUtestforordereddataandChi-squaretestforfrequencies.ThePearson’slinearcorrelationcoe -cientwasusedtomeasurethestrengthofdependencebetweentwovariables.TypeIstatisticerrorp-value<0.01wastakentobesigni cant.
Results
ThebaselineSnellenBCVArangedfrom0.1to0.5.FAshowedpredomi-nantlyclassicCNVin13%eyes,min-imallyclassicin16.7%,predominantlyclassicin44.4%andoccultsubfovealin25.9%.ThebaselinemeanlineardimensionsofthelesionsmeasuredonFAwas3502.4lm(min1125lm–max6680lm).MeanCRTwas479.3lm(min204lm–max864lm)asdemon-stratedbyOCT.
Atbaselineexamination,94(95.5%)ofthe98patientswithexudativeAMDwerepositiveforARAsattitresrang-ingfrom1:40to1:5120.Thehighest
titreswerefoundinpatientswithbilateralCNV(n=10)(1:160–1:5120).InpatientswithCNVinoneeyeandsoftdrusenand/orRPEdisturbancesintheother(n=54)titresrangedfrom1:80to1:640.IncaseswithadisciformscarinoneeyeandCNVintheother(n=30),ARAsweredetectedintitresrangingfrom1:40to1:160.InthecontrolgroupARAswerepresentin32%ofcasesrangingfrom1:10to1:40.Thedi erencesbetweenserumlevelsofARAsinAMDpatientsandcon-trolswerestatisticallysigni cant(p=0.0000,Mann-WhitneyUtest)(Fig.1).
InpatientswithAMD veimmuno- uorescencepatternsofARAswereobserved,whilecontrolserademon-stratedfourstainingpatternsofreactiv-ityagainstretinaltissue.Di erencesinARAsstainingtypesinAMDandcontrolswerestatisticallysigni cant(p=0.0000).Theseraof61.2%patientswithAMDshowedmorethanoneimmuno uorescencetype,whileincon-trolgroupthecomplexityofARAsimmuno uorescencepatternswasobservedinonly15%.Immuno uores-cencepatternsofARAofAMDpatientsandcontrolsareshowninFig.2.
InAMDgroupapositivereactionwithintheouterandinnernuclearlayersofmonkeyretinawerepresentin21patients(21.4%).Thetitresoftheseautoantibodiesrangedfrom1:10to1:160.Nineteenserashowedthehomogenousimmuno uorescencepat-tern,whiletwodemonstratedthespeckledtypeofreaction.TheIIFtestperformedonHEp-2celllinescon- rmedthepresenceofANAinallthesecaseswitharangeoftitresasthesameasonmonkeyretina.AllANApositiveserademonstratedadditionalpositivereactionwithinotherlayersofretina:cones,rods,ganglioncellslayerornerve berlayer.AcontrolgroupshowedthepresenceofANAusingIIFtestwithHEp-2cellslinein13sera(26%)withtitresrangedfrom1:40to1:160.
AtbaselineexaminationapositivecorrelationwasfoundbetweentitresofARAs,thediameterofCNVmea-suredbyFA(p=0.0000,Chi-squaretest)andCRTassessedbyOCT(p=0.0000).Astatisticallysigni cantcorrelationwasnotedbetweenmeantitresofARAsandthemorphologyofCNV(p=0.0002);highmeantitreswereobservedinpatientswithmini-
2
Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes...Acute and chronic immunological response to dietary antigen. Gut 1983;24:831...
Circulating Tumor Cells, Disease Progression, and ...response to treatment was determined with the use...Fluorescently labeled monoclonal antibodies specific ...
response against a large variety of self molecules in pSS patients, and, ...the majority of anti-CA antibodies correlated with other circulating autoantibodie...
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and...Correlations Anti-endothelial with renal injury and circulating markers of endoth...
A response rate of 65% is typically observed at...increase in the number of circulating platelets in...Anti-idiotype antibodies Inhibits complement ...
tested its potential utility in monitoring response to anti-cancer therapy. ...anti-cytokeratin (also known as KERSMCR) antibodies for epithelial cells, ...
Circulating mitochondrial DAMPs cause_基础医学_医药卫生...(MMP)-2) antibodies have no effects (...in response to MTD (Fig. 2e, f) more rapidly...
The role of the circulating CD20+ B cells in ...In addition, the following antibodies were used ...leukemia: an evaluation of response to therapy. ...
Secreted from liver cells, circulating PCSK9 binds...Whether anti-PCSK9 antibodies will reduce the ...and the response to high-dose statin therapy. J...
circulating cancer cells than solid tumors beavoid,...antibodies for cancer diagnosis and therapy. Expert...133 REVIEW acts as an anti-angiogenic cocktail. ...
热门文档